The FDA accepts Aldeyra's resubmitted NDA for topical ocular reproxalap to treat the signs and symptoms of dry eye disease.

On Monday, Aldeyra Therapeutics Inc (ALDX) stock saw a modest uptick, ending the day at $4.7 which represents a slight increase of $0.49 or 11.64% from the prior close of $4.21. The stock opened at $4 ...

Comcast Corp. plans to spin off cable-TV channels including MSNBC, CNBC and USA, according a person a familiar with the ...

Weakness in AmericaFirst Monthly Risk-On Risk-Off U's Process and People Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative. Our research team assigns Negative ...

Trump Defies the #MeToo Movement With Cabinet Picks Facing Accusations Donald Trump, who was found liable for sexual abuse last year, appears determined to force a fight over the role of such ...

Stewart-Haas' sad demise belies its legacy of unlikely success (October 31, 2024, 7:00 PM ET) ...

Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...

Phuket is a province in the south of Thailand. Phuket's beaches face the Andaman Sea allowing the west coast beaches fantastic sunsets right throughout the year. If ...

Get dialed in every Tuesday & Friday with quick updates on the world of crypto ...